NOTCH1 and acute lymphoblastic leukemia: Indeed, the inhibition of glutaminolysis using a specific inhibitor (BPTES) synergistically enhances the anti-leukemic effects of anti-NOTCH1 therapy in a mouse model of T-ALL [93].